Sio Capital Management as of Dec. 31, 2024
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 51 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Icon SHS (ICLR) | 11.5 | $41M | 196k | 209.71 | |
| Maximus (MMS) | 8.0 | $29M | 381k | 74.65 | |
| Cigna Corp (CI) | 7.6 | $27M | 98k | 276.14 | |
| Labcorp Holdings Com Shs (LH) | 7.3 | $26M | 113k | 229.32 | |
| Sanofi Sponsored Adr (SNY) | 5.3 | $19M | 387k | 48.23 | |
| Zimmer Holdings (ZBH) | 5.2 | $19M | 175k | 105.63 | |
| Bright Minds Biosciences Com New (DRUG) | 4.6 | $16M | 452k | 36.02 | |
| Anteris Technologies Global (AVR) | 3.7 | $13M | 2.4M | 5.58 | |
| Annexon (ANNX) | 3.4 | $12M | 2.4M | 5.13 | |
| Teleflex Incorporated (TFX) | 3.3 | $12M | 67k | 177.98 | |
| Viatris (VTRS) | 2.6 | $9.1M | 730k | 12.45 | |
| Organon & Co Common Stock (OGN) | 2.5 | $9.0M | 606k | 14.92 | |
| Ventyx Biosciences (VTYX) | 2.5 | $8.9M | 4.0M | 2.19 | |
| Biosante Pharmaceuticals (ANIP) | 2.5 | $8.8M | 160k | 55.28 | |
| Embecta Corp Common Stock (EMBC) | 2.5 | $8.8M | 426k | 20.65 | |
| Vir Biotechnology (VIR) | 2.2 | $7.7M | 1.1M | 7.34 | |
| Vaxart Com New (VXRT) | 2.1 | $7.6M | 12M | 0.66 | |
| Protara Therapeutics Com Stk (TARA) | 2.1 | $7.6M | 1.4M | 5.28 | |
| Cargo Therapeutics (CRGX) | 1.9 | $6.8M | 473k | 14.42 | |
| Neumora Therapeutics (NMRA) | 1.9 | $6.7M | 636k | 10.60 | |
| Septerna (SEPN) | 1.8 | $6.2M | 272k | 22.90 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 1.5 | $5.4M | 2.1M | 2.65 | |
| Pmv Pharmaceuticals (PMVP) | 1.5 | $5.4M | 3.6M | 1.51 | |
| Disc Medicine (IRON) | 1.3 | $4.7M | 74k | 63.40 | |
| Astria Therapeutics (ATXS) | 1.3 | $4.5M | 505k | 8.94 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 1.1 | $4.0M | 908k | 4.43 | |
| CryoLife (AORT) | 1.0 | $3.5M | 121k | 28.59 | |
| Erasca (ERAS) | 1.0 | $3.4M | 1.4M | 2.51 | |
| Tyra Biosciences (TYRA) | 0.9 | $3.3M | 241k | 13.90 | |
| Ideaya Biosciences (IDYA) | 0.9 | $3.2M | 123k | 25.70 | |
| Alpha Cognition Com New (ACOG) | 0.7 | $2.6M | 435k | 5.89 | |
| Q32 Bio (QTTB) | 0.7 | $2.4M | 697k | 3.44 | |
| Tela Bio (TELA) | 0.5 | $1.9M | 630k | 3.02 | |
| Nuvation Bio Com Cl A (NUVB) | 0.5 | $1.8M | 668k | 2.66 | |
| Context Therapeutics (CNTX) | 0.4 | $1.4M | 1.3M | 1.05 | |
| Alector (ALEC) | 0.3 | $1.2M | 616k | 1.89 | |
| Enanta Pharmaceuticals (ENTA) | 0.3 | $1.0M | 177k | 5.75 | |
| Ovid Therapeutics (OVID) | 0.3 | $934k | 1.0M | 0.93 | |
| Aprea Therapeutics Com New (APRE) | 0.3 | $910k | 277k | 3.29 | |
| Foghorn Therapeutics (FHTX) | 0.2 | $574k | 122k | 4.72 | |
| C4 Therapeutics Com Stk (CCCC) | 0.2 | $558k | 155k | 3.60 | |
| Avalo Therapeutics Com New (AVTX) | 0.1 | $531k | 72k | 7.43 | |
| Boundless Bio (BOLD) | 0.1 | $470k | 162k | 2.90 | |
| Nyxoah S A SHS (NYXH) | 0.1 | $407k | 51k | 8.00 | |
| Modular Med Com New (MODD) | 0.1 | $345k | 252k | 1.37 | |
| Mesoblast Spons Adr (MESO) | 0.1 | $230k | 12k | 19.80 | |
| Nextcure (NXTC) | 0.0 | $100k | 130k | 0.77 | |
| Humacyte *w Exp 08/27/202 (HUMAW) | 0.0 | $92k | 50k | 1.83 | |
| Terns Pharmaceuticals (TERN) | 0.0 | $55k | 10k | 5.54 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $15k | 400k | 0.04 | |
| Savara (SVRA) | 0.0 | $12k | 3.7k | 3.07 |
